Albuminuria in non-insulin-dependent diabetes mellitus: Prevalence, causes, and consequences

Danish Medical Bulletin

Volumn 44, Issue 5, 1997, Pages 465-485

  Gall, Mari Anne ^a  

^a STENO DIABETES CENTER   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C PEPTIDE; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTERIAL PRESSURE; CARDIOVASCULAR DISEASE; CAUCASIAN; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; ETHNOLOGY; FEMALE; GENETIC PREDISPOSITION; GLOMERULUS FILTRATION RATE; HIGH RISK PATIENT; HUMAN; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEINURIA; REVIEW; SMOKING; URINARY EXCRETION;

ADULT; AGED; ALBUMINURIA; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS;

EID: 0030656338     PISSN: 09078916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (238)

1. Alberti KGMM (1993): Problems related to definitions and epidemiology of Type 2 (non-insulin-dependent) diabetes mellitus: studies throughout the world. Diabetologia 36: 978-84.
2. Amoah E, Glickman JL, Malchoff CD, Sturgill BC, Kaiser DL, Bolton WK (1988): Clinical identification of nondiabetic renal disease in diabetic patients with Type I and Type II disease presenting with renal dysfunction. Am J Nephrol 8: 204-11.
3. Anderson S, Brenner B (1988): Pathogenesis of diabetic glomerulopathy: Hemodynamic considerations. Diabetes Metab Rev 4: 163-77.
4. Andersson DKG, Svärdsuud K (1995): Long-term glycemic control relates to mortality in Type II diabetes. Diabetes Care 18: 1534-43.
5. Baba T, Murabayashi S, Tomiyama T, Takebe K (1990): Uncontrolled hypertension is associated with a rapid progression of nephropathy in Type 2 diabetic patients with proteinuria and preserved renal function. Tohoku J Exp Med 161: 311-8.
6. Baba T, Tomiyama T, Kodama T, Murabayashi S (1992): Glycaemic control and progression of nephropathy in proteinuric NIDDM patients. Diabetes Res Clin Pract 16: 157-9 (Letter).
7. Ballard DJ, Humphrey LL, Melton III J, Frohnert PP. Chu-Pin C. O'Fallon WM, Palumbo PJ (1988): Epidemiology of persistent proteinuria in Type II diabetes mellitus. Diabetes 37: 405-12.
8. Berkman J, Rifkin H (1973): Unilateral nodular diabetic glomerulosclerosis (Kimmelstiel-Wilson). Report of a case. Metabolism 22: 715-22.
9. Bilous RW, Mauer SM, Sutherland DER, Steffes MW (1989): Mean glomerular volume and rate of development of diabetic nephropathy. Diabetes 38: 1142-7.
10. Blackburn H. Keys, A, Simonsen E, Rautaharju P, Punsar S (1960): The electrocardiogram in population studies: a classification system. Circulation 21: 1160-75.
11. Boerwinkle E, Turner ST, Weinshilboum R, Johnson M, Richelson E, Sing CF (1986): Analysis of the distribution of erythrocyte sodium-lithium countertransport in a sample representative of the general population. Genet Epidemiol 3: 365-78.
12. Borch-Johnsen K, Kreiner S (1987): Proteinuria: value as predictor of cardiovascular mortality in insulin-dependent diabetes mellitus. Br Med J 294: 1651-4.
13. Borch-Johnsen K (1989): The prognosis of insulin-dependent diabetes mellitus. An epidemiological approach. Thesis. Dan Med Bull 36: 336-48.
14. Brenner B (1983): Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int 23: 647-55.
15. Brownlee M (1992): Glycation products and the pathogenesis of diabetic complications. Diabetes Care 15: 1835-43.
16. 51Cr-EDTA. Scand J Clin Lab Invest 23: 301-5.
17. Bröchner-Mortensen J (1972): A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest 30: 271-4.
18. Bröchner-Mortensen J., Rödbro P (1976a): Selection of a routine method for determination of glomerular filtration rate in adult patients. Scand J Clin Lab Invest 36: 35-43.
19. 51Cr]EDTA. Scand J Clin Lab Invest 36: 247-9.
20. Canessa M, Adragna N, Solomon HS; Connolly TM, Tosteson DC (1980): Increased sodium-lithium countertransport in red cells of patients with essential hypertension. N Engl J Med 302: 772-6.
21. Chan JCN, Cockram CS, Nicholls MG, Cheung CK, Swammathan R (1992): Comparison of enalapril and nifedipine in treating non-insulin dependent diabetes associated with hypertension: one year analysis. Br Med J 305: 981-5.
22. Chen J-W, Gall M-A, Decken M, Jensen JS, Parving H-H (1995): Increased serum concentration of von Willebrand in non-insulin-dependent diabetic patients with and without diabetic nephropathy. Br Med J 311: 1405-6.
23. Chihara J, Takebayashi, Taguchi T, Yokoyama K, Harada T, Naito S (1986): Glomerulonephritis in diabetic patients and its effect on the prognosis Nephron 43: 45-9.
24. Christensen C, Ørskov C (1984): Rapid screening PEG radioimmunoassay for quantification of pathological rnicroalbuminuria. Diabetic Nephropathy 3: 92-4.
25. Christensen EI, Rennke HG, Carone FA (1983): Renal tubular uptake of protein: effect of molecular charge. Am J Physiol 244: F436-41.
26. Christiansen JS (1984): On the pathogenesis of increased glomerular filtration rate in short-term insulin-dependent diabetes. Thesis. Dan Med Bull 31: 349-61.
27. Chung J, Sobin LH (1982): Renal disease, Classification and atlas of glomerular disease. Igaku-Shoin, Tokyo, New York.
28. Collins VR, Dowse GK, Finch CF, Zimmet PZ, Linnane AW (1989): Prevalence and risk factors for micro- and macroalbuminuria in diabetic-subjects and entire population of Nauru. Diabetes 38: 1602-10.
29. Copenhagen City Heart Study Questionnaire 1981-83 Copenhagen, 1981, p. 151-152.
30. Cowie CC, Port FK, Wolfe RA, Savage PJ, Moll PP, Hawthorne VM (1989): Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. N Engl J Med 321: 1074-9.
31. Damsgaard EM, Mogensen CE (1986): Microalbuminuria in elderly hyper-glycaemic patients and controls. Diabetic Med 3: 430-5.
32. Damsgaard EM, Frøland A, Jørgensen OD, Mogensen CE (1990): Microal-buminuria as predictor of increased mortality in elderly people. Br Med J 300: 297-300.
33. Damsgaard EM, Frøland A, Jørgensen OD, Mogensen CE (1992): Eight to nine year mortality in known non-insulin-dependent diabetics and controls. Kidney Int 41: 731-5.
34. Dasmahapatra A, Bale A, Raghuwanshi MP, Reddi A, Byrne W, Suarez S, Nash F, Varagiannis E, Skumick JH (1994): Incipient and overt diabetic nephropathy in African Americans with NIDDM. Diabetes Care 17: 297-304.
35. Decken T, Parving H-H, Andersen AR, Christiansen JS, Oxenbøll B, Svendsen PAa, Telmer S, Christey M, Lauritzen T, Thomsen OF, Kreiner S, Andersen JR, Binder C, Nerup J (1982): Diabetic nephropathy. A clinical and morphometric study. In: Eschwege E (ed). Advances in diabetes epidemiology. INSERM Symposium No. 22, pp 235-43. Elsevier Biomedical Press B.V.
36. Deckert T, Feldt-Rasmussen B, Djurup R, Decken M (1988): Glomerular size and charge selectivity in insulin-dependent diabetes mellitus. Kidney Int 33: 100-6.
37. Decken T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A (1989): Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 32: 219-26.
38. Decken T, Kofoed-Enevoldsen A, Vidal P, Norgaard K, Andreascn HB, Feldt-Rasmussen B (1993): Size- and charge selectivity of glomerular filtration in Type I (insulin-dependent) diabetic patients with and without albuminuria. Diabetologia 36: 244-51.
39. Deen WM, Bridges CR, Brenner BM, Myers BD (1985): Heteroporous model of glomerular size-selectivity: application to normal and nephrotic humans. Am J Physiol 249: F374-89.
40. Diabetes Control and Complications Trial Research Group (1993): The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-86.
41. Diabetes Drafting Group (1985): Prevalence of small vessel and large vessel disease in diabetics. The World Health Organisation multinational study of vascular disease in diabetics. Diabetologia 28: 615-40.
42. Ellis EN, Steffes MW, Goetz FC, Sutherland DER, Mauer SM (1986): Glomerular filtration surface in type 1 diabetes mellitus. Kidney Int 29: 889-94.
43. Ewing DJ, Campbell JW, Clarke BF (1980): The natural history of diabetic autonomic neuropathy. Q J Med 49: 95-100.
44. Faber OK, Binder C (1977): C-peptide response to glucagon: a test for the residual β-cell function in diabetes mellitus. Diabetes 26: 605-10.
45. Fabre J, Balant LP, Dayer PG, Fox HM, Vernet AT (1982): The kidney in maturity onset diabetes mellitus: A clinical study of 510 patients. Kidney Int 21: 730-8.
46. Falkenberg M, Finnström (1994): Associations with retinopathy in Type 2 diabetes: a population-based study in a Swedish rural area. Diabetic Med 11: 843-9.
47. Feldt-Rasmussen B, Mathiesen ER (1984): Variability of urinary albumin excretion in incipient diabetic nephropathy. Diabetic Nephropathy 3: 101-3.
48. Feldt-Rasmussen B, Borch-Johnsen K, Decken T, Jensen G, Jensen JS (1994): Microalbuminuria: An important diagnostic tool. J Diab Comp 8: 137-45.
49. Fomsgaard A, Feldt-Rasmussen B, Decken M, Dinesen B (1987): Micro-ELISA for the quantilation of human urinary IgG. Scand J Clin Lab Invest 47: 195-8.
50. Friedman R, Gross JL (1991): Evolution of glomerular filtration rate in proteinuric NIDDM patients. Diabetes Care 14: 355-9.
51. Frimondt-Møller C (1978): Diabetic cystopathy. Dan Med Bull 25: 49-60.
52. Frohlich ED, Apstein C, Chobanian AV, Devereux RB, Dustan HP, Dzau V, Fauad-Tarazi F, Horan MJ, Marcus M, Massie B, Pfeffer MA, Re RN, Roccella EJ, Savage D, Shub C (1992): The heart in hypertension. N Engl J Med 327: 998-1008.
53. Fujita J, Tsuda K, Seno M, Obayashi H, Fukui I.,Seino Y (1994): Erythrocyte sodium-lithium countertransport activity as a marker of predisposition to hypertension and diabetic nephropathy. Diabetes Care 17: 977-82.
54. Funder J, Tosteson D, Wieth JD (1978): Effects of bicarbonate on lithium transport in human red cells. J Gen Physiol 71: 720-46.
55. Gall M-A, Rossing P, Skott P, Damsbo P, Vaag A, Bech K, Dejgaard A, Lauritzen M, Lauritzen E, Hougaard P, Beck-Nielsen H, Parving H-H (1991a): Prevalencc of micro- and macroalbuminuria, arterial hypertension. retinopathy and large vessel disease in European Type 2 (non-insulm-dependent) diabetic patients. Diabetologia 34: 655-61.
56. Gall M-A, Rossing P, Jensen JS, Funder J, Parving H-H (1991b): Red cell Na+/Li+ countertransport in non-insulin-dependent diabetics with diabetic nephropathy. Kidney Int 39: 135-40.
57. Gall M-A, Nielsen FS, Smidt UM, Parving H-H (1993): The course of kidney function in Type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy. Diabetologia 36: 1071-8.
58. Gall M-A, Nielsen FS, Smidt UM, Parving H-H (1994a): The course of kidney function in non-diabetic patients with diabetic or non-diabetic glomerulopathy. Diabetologia 37 (suppl. 1): A15 (Abstract).
59. Gall M-A, Rossing P, Kofoed-Enevoldsen A, Nielsen FS, Parving H-H (1994b): Glomerular size- and charge selectivity in Type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy. Diabetologia 37: 195-201.
60. Gall M-A, Borch-Johnsen K, Hougaard P, Nielsen FS, Parving H-H (1995): Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes 44: 1303-9.
61. Gambara V, Mecca G, Remuzzi G, Bertani T (1993): Heterogenous nature of renal lesions in Type II diabetes. J Am Soc Nephrol 3: 1458-66.
62. Gjessing HJ, Matzen LE, Faber OK, Frøland A (1989): Fasting plasma C-peptide, glucagon stimulated plasma C-peptide, and urinary C-peptide in relation to clinical type of diabetes. Diabetologia 32: 305-11.
63. Gragnoli G, Signorini AM, Tanganelli I, Fondelli C, Borgogni P, Borgogni L, Valtimo A, Ferrari F, Guercia M (1993): Prevalence of glomerular hyper-filtration and nephromegaly in normo- and microalbuminuric Type 2 diabetic patients. Nephron 65: 206-11.
64. Grenfell A, Bewick M, Parsons V, Snowden S, Taube D, Watkins PJ (1988): Non-insulin-dependent diabetes and renal replacement therapy. Diabetic Med 5: 172-6.
65. Groop L, Ekstrand A, Forsblom C, Widen E, Groop P-H, Eriksson J (1993): Insulin resistance, hypertension and microalbuminuria in patients with Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 36: 642-7.
66. Gundersen HJG, Bendtsen TF, Korbo L, Marcussen N, Møller A, Nielsen K, Nyengaard JR, Pakkenberg B, Sørensen FB, Vesterby A, West MJ (1988): Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS 96: 379-94.
67. Harris MI, Klein R, Welborn TA, Knuiman MW (1992): Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care 15: 815-9.
68. Haffner SM, Mitchell BD, Pugh JA, Stern MP, Kozlowski MK, Hazuda HP, Patterson JK, Klein R (1989): Proteinuria in Mexican Americans and non-Hispanic Whites with NIDDM. Diabetes Care 12: 530-6.
69. Hasslacher C, Ritz F, Wahl P, Michael C (1989): Similar risks of nephropathy in patients with Type I or Type II diabetes mellitus. Nephrol Dial Transplant 4: 859-63.
70. Hasslacher C, Bostedt-Kiesel A, Kempe HP, Wahl P (1993): Effect of metabolic factors and blood pressure on kidney function in proteinuric Type 2 (non-insulin-dependent) diabetic patients. Diabetologia 36: 1051-6.
71. Hayashi H, Karasawa R, Inn H, Saitou T, Ueno M, Nishi S, Suzuki Y, Ogino S, Maruyama Y, Kouda Y, Arakawa M (1992): An electron microscopic study of glomeruli in Japanese patients with non-insulin dependent diabetes mellitus. Kidney Int 41: 749-57.
72. Herman WH, Prior DE, Yassine MD, Weder AB (1993): Nephropathy in NIDDM is associated with cellular markers of hypertension. Diabetes Care 16: 815-8.
73. Hirose K, Østerby R, Nozawa M, Gundersen HJG (1982): Development of glomerular lesions in experimental long-term diabetes in the rat. Kidney Int 21: 689-95.
74. Hostetter TH, Troy JL, Brenner BM (1981a): Glomerular hemodynamics in experimental diabetes. Kidney Int 19: 410-15.
75. Hosletter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM (1981b): flyperfiltration in remnant nephrons: a potenlially adverse response to renal ablation. Am J Physiol 241 : F85-93.
76. Hostetter TH, Rennke HG, Brenner BM (1982): The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 72: 375-80.
77. Hother-Nielscn O, Faber O, Sørenscn NS, Beck-Nielsen H (1988): Classification of newly diagnosed diabetic patients as insulin-requiring or non-insulin-requiring based on clinical and biochemical variables. Diabetes Care 11: 531-7.
78. Humphrey LL, Ballard DJ, Frohnert PP, Chu C-P, O'Fallon M, Palumbo PJ (1989): Chronic renal failure in non-insulin-dependent diabetes mellitus. A population-based study in Rochester, Minnesota. Ann Intern Med 111: 788-96.
79. Huse DM, Oster G, Killen AR, Lacey MJ, Colditz GA (1989): The economic-costs of non-insulin-dependent diabetes mellitus. JAMA 262: 2708-13.
80. Ibsen KK, Jensen HÆ, Wieth JD, Funder J (1982): Essential hypertension: Sodium-lithium countertransport in erythrocytes from patients and from children having one hypertensive parent. Hypertension 4: 703-9.
81. Jacobson HR (1991): Chronic renal failure: pathophysiology Lancet 338: 419-23.
82. Jameel N, Pugh JA, Mitchell BD, Stern MP (1992): Dietary protein intake is not correlated with clinical proteinuria in NIDDM. Diabetes Care 15: 178-83.
83. Jarrett RJ, Viberti GC, Argyropoulos A, Hill RD, Mahmud U, Murrells TJ (1984a): Microalbuminuria predicts mortality in non-insulin-dependent diabetes. Diabetic Med 1: 17-9.
84. Jarrett RJ (1984b): The epidemiology of coronary heart disease and related factors in the context of diabetes mellitus and impaired glucose tolerance. In: Jarrett RJ (ed). Diabetes and heart disease, pp 1-23. Elsevier Science Publishers, Amsterdam.
85. Jensen FB, Gundersen HJG, Østerby R (1979): Determination of membrane thickness distribution from orthogonal intercepts. J Microsc 115: 19-33.
86. Jensen T, Bjerre-Knudsen J, Feldt-Rasmussen B, Decken T (1989): Features of endothelial dysfunction in early diabetic nephropathy. Lancet i: 461-3.
87. John L, Sunder Rao PSS, Kanagasabapathy AS (1994a): Rate of progression of albuminuria in Type II diabetes. Five-year prospective study from South India. Diabetes Care 17: 888-90.
88. John L, Mathews P, Oommnen R (1994b): Glomerular filtration rate in Indian non-insulin-dependent diabetics at various stages of albuminuria. Diabetes Res Clin Pract 23: 121-5.
89. Jones SL, Close CF, Mattock MB, Jarrett RJ, Keen H, Viberti GC (1989): Plasma lipid and coagulation factor concentrations in insulin dependent diabetics with microalbuminuria. Br Med J 298: 48790.
90. Kannel WB, Gordon T, Schwans MJ (1971): Systolic versus diastolic blood pressure and risk of coronary heart disease: the Framingham study. Am J Cardiol 27: 335-46.
91. Kaplan C, Pasternack B, Shah H, Gallo G (1975): Age-related incidence of sclerotic glomeruli in human kidneys. Am J Pathol 80: 227-34.
92. Kasiske BL, O'Donnell MP, Cleary MP, Keane WF (1988a): Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. Kidney Int 33: 667-72.
93. Kasiske BL, O'Donnell MP, Garvis WJ, Keane WF (1988b): Pharmacologic treatment of hyperlipidemia reduces glomerular injury in rat 5/6 nephrectomy model of chronic renal failure. Circ Res 62: 367-74.
94. Kasiske BL, Kalil RSN, Ma JZ, Liao M, Keane WF (1993): Effect of antihypertensive therapy on the kidney in patients with diabetes: A meta-regression analysis. Ann Intern Med 118: 129-38.
95. Keen H (1986): What's in a name? IDDM/NIDDM, Type 1/Type 2. Diabetic Med 3: 11-2.
96. Kimmelstiel P & Wilson C (1936): Intercapillary lesions in glomeruli of the kidney. Am J Pathol 12: 82-97.
97. Klein R, Klein BEK, Moss S, DeMets DL (1988): Proteinuria in diabetes. Arch Intern Med 148: 181-6.
98. Klein R, Klein BEK, Moss SE (1993a): Prevalence of microalbuminuria in older-onset diabetes. Diabetes Care 16: 1325-30.
99. Klein R, Klein BEK, Moss SE (1993b): Incidence of gross proteinuria in older-onset diabetes. A population-based perspective. Diabetes 42: 381-9.
100. Knuiman MW, Welborn TA, Whittall DE (1992): An analysis of excess mortality rates for persons with non-insulin-dependent diabetes mellitus in Western Australia using the Cox proportional hazards regression model. Am J Epidemiol 135: 638-48.
101. Kofoed-Enevoldsen A (1995). Heparan sulphate in the pathogenesis of diabetic nephropathy. Diabetes/Metabolism Reviews 11: 137-60.
102. Krolewski AS, Canessa M, Warram JH, Laffel LMB, Chrisllieb AR, Knowler WC, Rand LI (1988): Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med 318: 140-5.
103. Kunzelman CL, Knowler WC, Pettitt DJ, Bennettt PH (1989): Incidence of proteinuria in type 2 diabetes mellitus in the Pima Indians. Kidney Int 35: 681-87.
104. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M (1994): NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 43: 960-7.
105. Laakso M, Rönnemaa T, Letho S, Puukka P, Kallio V, Pyörälä (1995): Does NIDDM increase the risk for coronary heart disease similarly in both lowand high-risk populations? Diabetologia 38: 487-93.
106. Lacourcière Y, Nadeau A, Poirier L, Tancrède G (1993): Caplopri or conventional therapy in hypertensive Type II diabetics. Three-year analysis. Hypertension 21: 786-94.
107. Lane PH, Steffes MW, Mauer SM (1992): Estimation of glomerular volume: a comparison of four methods. Kidney Int 41: 1085-9.
108. Larsen S (1978a): Immunofluorescent microscopy findings in minimal or no change-disease and slight generalised mesangioproliferalive glomerulo-nephritis. Acta Path Microbiol Scand 86: 531-42.
109. Larsen S (1978b): Immune deposits in generalized mesangioproliferative glomerulonephritis. Acta Path Microbiol Scand 86: 543-52.
110. Lebovitz HE, Palmisano J (1990): Cross-sectional analysis of renal function in black Americans with NIDDM. Diabetes Care 13 (suppl 4): 1186-90.
111. Leboviu HE, Wiegman TB, Cnaan A, Shahinfar S, Sica DA, Broadstone V, Schwartz SL, Mengel MC, Segal R, Versaggi JA, Bollon WK (1994): Renal protective effects of enalapril in hypertensive NIDDM: Role of baseline albuminuria. Kidney Int 45 (suppl. 45): 150-5.
112. Madsbad S, Krarup T, McNair P.,Christiansen C, Faber OK, Transbøl I, Binder C (1981): Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes mellitus. Act Med Scand 210: 153-6.
113. Mangili R, Bending JJ, Scott G, Li LK, Gupta A, Viberti GC (1988): Increased sodium-lithium countenransport activity in red cells of patients with insulin-dependent diabetes and nephropathy. N Engl J Med 318: 146-50.
114. Marshall SM, Alberti KGMM (1989): Comparison of the prevalence and associated features ot abnormal albumin excretion in insulin-dependent and non-insulin-dependent diabetes. Quart J Med 261: 61-71.
115. Mathiesen ER (1993): Prevention of diabetic nephropathy: Microalbuminuria and perspectives for intervention in insulin-dependent diabetes. Thesis. Dan Med Bull 40: 273-85.
116. Mattock MB, Keen H, Viberti GC, El-Gohari MR, Murrells TJ, Scott GS, Wing JR, Jackson PG (1988): Coronary heart disease and urinary albumin excretion rate in Type 2 (non-insulin-dependent) diabetic patients. Diabeto-logia 31: 82-7.
117. Mattock MB, Morrish NJ, Viberti GC, Keen H, Fitzgerald AP, Jackson (1992): Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes 41: 736-41.
118. Mauer SM, Steffes MW, Ellis EN, Sutherland DER, Brown DM, Goetz FC (1984): Structural-functional relationships in diabetic nephropathy. J Clin Invest 74: 1143-55.
119. McDonald A, Trevisan M, Cooper R, Stamler R, Gosch F, Ostrow D, Stamler J (1987): Epidemiological studies of sodium transport and hypertension. Hypertension 10 (suppl.1): 42-7.
120. McNally PG, Cooper MH (1994): Antihypertensive treatment in NIDDM, with special reference to abnormal albuminuria. In: Mogensen CE (ed). The kidney and hypertension in diabetes mellitus, 2nd edn. pp 341-51. Kluwer Academic Press, Boston.
121. Melbourne Diabetic Nephropathy Study Group (1991): Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria Br Med J 302: 210-6.
122. Mogensen CE, Sølling K (1977): Studies on renal tubular protein reabsorption: partial and near complete inhibition by certain amino acids Scand J Clin Lab Invest 37: 477-86.
123. Mogensen CE (1982): Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy Br Med J 285: 685-8.
124. Mogensen CE (1984): Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310: 356-60.
125. Mogensen CE, Chachati A, Christensen CK, Close CF, Decken T, Hommel E, Kastrup J, Lefevre P, Mathiesen ER, Feldt-Rasmussen B, Schmitz A, Viberti GC (1985-86): Microalbuminuria: An early marker of renal involvement in diabetes. Uremia Invest 9: 85-95.
126. Mogensen CE, Schmitz A, Christensen CK (1988): Comparative renal patho-physiology relevant to IDDM and NIDDM patients. Diabetes Metab Rev 4: 453-83.
127. Mogensen CE (1994): Definition of diabetic renal disease in insulin-dependent diabetes mellitus based on renal function tests. In: Mogensen CE (ed). The kidney and hypertension in diabetes mellitus, 2nd edn. pp 1-14. Kluwer Academic Press, Boston.
128. Moorhead JF, El-Nahas M, Chan MK, Varghese Z (1982): Lipid nephroloxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet II: 1309-11.
129. Morano S, Pietravalle P, De Rossi MG, Mariana G, Christina G, Medici F, Sensi M, Andreani D, Di Mario U (1993): A charge selective impairment in protein permselectivity is present in type 2 diabetes. Acta Diabetol 30: 138-42.
130. Morrish NJ, Stevens LK, Head J, Fuller JH, Jarrett RJ, Keen H (1990a): A prospective study of mortality among middle-aged diabetic patients (the London cohort of the WHO Multinational Study of Vascular Disease in Diabetics) I: causes and death rates. Diabetologia 33: 538-41.
131. Morrish NJ, Stevens LK, Head J, Fuller JH, Jarrett RJ, Keen H (1990b): A prospective study of mortality among middle-aged diabetic patients (the London cohort of the WHO Multinational Study of Vascular Disease in Diabetics) II: associated risk factors. Diabetologia 33: 542-8.
132. 1c by thinlayer isoelectric focusing. J Chromatogr 182: 325-33.
133. Moss SE, Klein R, Klein BEK, Meuer SM (1994): The association of glycemia and cause-specific mortality in a diabetic population. Arch Intern Med 154: 2473-9.
134. Mulec H, Johnsen SAa, Wiklund O, Björck S (1993): Cholesterol: A renal risk factor in diabetic nephropathy? Am J Kidney Dis 22: 196-201.
135. Myers BD, Nelson RG, Williams GW, Bennett PH, Hardy SA, Berg RL, Loon N, Knowler WC, Mitch WF, (1991): Glomerular function in Pima Indians with noninsulin-dependent diabetes mellitus of recent onset. J Clin Invest 88: 524-30.
136. Myers BD, Nelson RG, Tan M, Beck GJ, Bennett PH, Knowler WC, Blouch K, Mitch WE (1995): Progression of overt nephropathy in non-insulin-dependent diabetes mellitus. Kidney Int 47: 1781-9.
137. Nakamura Y, Myers BD (1988): Charge selectivity of proteinuria in diabetic glomerulopathy. Diabetes 37: 1202-11.
138. National Diabetes Data Group (1979): Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes: 28: 1039-57.
139. Neil A, Hawkins M, Potok M, Thorogood M, Cohen D, Mann J (1993): A prospective population-based study of microalbuminuria as a predictor of mortality in NIDDM. Diabetes Care 16: 996-1003.
140. Nelson RG, Pettitt DJ, Carraher MJ, Baird HR, Knowler WC (1988): Effect of proteinuria on mortality in NIDDM. Diabetes 37: 1499-1504.
141. Nelson RG, Kunzelman CL, Pettitt DJ, Saad MF, Bennett MF, Knowler WC (1989): Albuminuria in Type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance in Pima Indians. Diabetologia 32: 870-6.
142. Nelson RG, Knowler WC, Pettitt DJ, Saad MF, Charles MA, Bennett PH (1991): Assessment of risk of overt nephropathy in diabetic patients from albumin excretion in untimed urine specimens. Arch Intern Med 151: 1761-5.
143. Nelson RG, Knowler WC, McCance DR, Sievers ML, Pettitt DJ, Charles MA, Hanson RL, Liu QZ, Bennelt PH, (1993a): Determinants of end-stage renal disease in Pima Indians with Type 2 (non-insulin-dependent) diabetes mellitus and proleinuria. Diabetologia 36: 1087-93.
144. Nelson RG, Pettitt DJ, Baird HR, Charles MA, Liu QZ, Bennetl PH, Knowler WC (1993b): Pre-diabetic blood pressure predicts urinary albumin excretion after the onset of Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 36: 998-1001.
145. Nielsen FS, Rossing P, Bang LE, Svendsen TL, Gall M-A, Smidt UM, Parving H-H (1995). On the mechanisms of blunted nocturnal decline in arterial blood pressure in NIDDM patients with diabetic nephropathy. Diabetes 44: 783-9.
146. Nielsen S, Schmitz A, Rehling M, Mogensen CE (1993): Systolic blood pressure relates to the rate of decline of glomerular filtration rate in Type II diabetes. Diabetes Care 16: 1427-32.
147. Niskanen L, Uusitupa M, Sarlund H, Siitonen O, Voutilainen E, Penttila I, Pyörälä K (1990): Microalbuminuria predicts the development of serum lipoprotein abnormalities favouring atherogenesis in newly diagnosed Type 2 (non-insulin-dependent) diabetic patients. Diabetologia 33: 237-43.
148. Nørgaard K, Feldt-Rasmussen B, Borch-Johnsen K, Sælan H, Deckert T (1990): Prevalence of hypertension in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1990: 407-10.
149. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M (1995): Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study Diabetes Res Clin Pract 28: 103-17.
150. Olivarius N de F, Andreasen AH, Keidmg N, Mogensen CE (1993): Epidemiology of renal involvement in newly-diagnosed middle-aged and elderly diabetic patients. Cross-sectional data from the population-based study "Diabetes care in general practice". Diabetologia 36: 1007-16.
151. Oliver III JD, Anderson S, Troy JL, Brenner BM, Deen WM (1992): Determination of glomerular size-selectivity in the normal rat with ficoll. J Am Soc Nephrol 3: 214-28.
152. Pagtalunan ME, Miller PL, Nelson RG, Myers BD, Coplon N, Meyer TW (1994): Glomerular structure in Pima Indians with Type II diabetes mellitus. J Am Soc Nephrol 5: 381 (Abstract).
153. Panzram G (1987): Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 30: 123-31.
154. Parving H-H, Smidt UM, Friisberg B, Bonnevie-Nielsen V, Andersen AR (1981): A prospective study of glomerular filtration rate and arterial blood pressure in insulin-dependent diabetics with diabetic nephropathy. Diabetologia 20: 457-61.
155. Parving H-H, Oxenbøll B, Svendsen PAa, Christiansen JS, Andersen AR (1982): Early detection of patients at risk of developing diabetic nephropathy. Acta Endocrinol 100: 550-5.
156. Parving H-H, Hommel E, Mathiesen ER, Skøtt P, Edsberg B, Bahnsen M, Lauritzen M, Hougaard P, Lauritzen E (1988): Prevalence of microalbuminuria, arterial hypertension, retinopathy, and neuropathy in insulin-dependent diabetic patients. Br Med J 296: 156-60.
157. Parving H-H (1992a): Arterial hypertension in diabetes mellitus. In: Alberti KGMM, DeFronzo RA, Keen H, Zimmet P (eds). International textbook of diabetes mellitus, pp 1521-34. John Wiley & Sons Ltd, Chichester.
158. Parving H-H, Gall M-A, Skøtt P, Jørgensen HE, Løkkegaard H, Jørgensen F, Nielsen B, Larsen S (1992b): Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients. Kidney Int 41: 758-62.
159. Parving H-H, Østerby R, Anderson PW, Hsueh WA (1995): Diabetic nephropathy. In: Brenner BM (ed.), Brenner's The Kidney, 5th edn, pp 1864-92. Saunders, Philadelphia.
160. Perna A, Remuzzi G (1996): Abnormal permeability to proteins and glomerular lesions: A meta-analysis of experimental and human studies. Am J Kidney Dis 27: 34-41.
161. Pettitt DJ, Lisse JR, Knowler WC, Bennett, PH (1980): Development of retinopathy and proteinuria in relation to plasma-glucose concentrations in Pima Indians. Lancet II: 1050-2.
162. Pettitt DJ, Saad MF, Bennett PH, Nelson RG, Knowler WC (1990): Familial predisposition to renal disease in two generations of Pima Indians with Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 33: 438-43.
163. Pietravalle P, Morano S, Christina G, de Rossi MG, Mariani G, Cotroneo P, Ghirlanda G, Clementi A, Andreani D, di Mario U (1991). Charge selectivity of proteinuria in type 1 diabetes explored by Ig subclass clearance. Diabetes 40: 1685-90.
164. Pinkney JH, Foyle W-J, Denver AE, Mohammed-Ali V, McKinlay S, Yudkin JS (1995): The relationship of urinary albumin excretion rate to ambulatory blood pressure and erythrocyte sodium-lithium countertransport in NIDDM. Diabetologia 38: 356-62.
165. Pugh JA (1989): The epidemiology of diabetic nephropathy. Diabetes Metab Rev 5: 531-46.
166. Pugh JA, Medina R, Ramirez (1993): Comparison of the course to end-stage renal disease of Type 1 (insulin-dependent) and Type 2 (non-msulin-dependent) diabetic nephropathy. Diahetologia 36: 1094-8.
167. Pyörälä K, Laakso M, Uusitupa M (1987): Diabetes and atherosclerosis: an epidemiological view. Diabetes Metab Rev 3: 463-524.
168. Ravid M, Savin H, Lang R, Jutrin I, Shoshana L, Lishner M (1992): Proteinuria, renal impairment, metabolic control, and blood pressure in Type 2 Diabetes Mellitus. Arch Intern Med 152: 1225-9.
169. Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishner M (1993): Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive Type II diabetic patients. Ann Imern Med 118: 577-81.
170. Ravid M, Neumann L, Lishner M (1995): Plasma lipids and the progression of nephropathy in diabetes mellitus type II: Effect of ACE inhibitors. Kidney Int 47: 907-10.
171. Remuzzi G, Bertani T (1990): Editorial review: is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int 38: 384-94.
172. Remuzzi A, Remuzzi G (1994): Glomerular perm-selective function. Kidney Int 45: 398-402.
173. Rendell M, Zarriello J, Drew HM, Dranbauer B, Wilson G, Waud J, Ross D (1981): Recovery from decompensated non-insulin-dependent diabetes mellitus: studies of C-peptide secretion. Diabetes Care 4: 354-9.
174. Rettig B, Teutsch SM (1984): The incidence of end-stage renal disease in Type I and Type II diabetes mellitus. Diabetic Nephropathy 3: 26-7.
175. Richards NT, Greaves I, Lee SJ, Howie AJ, Adu D, Michael J (1992): Increased prevalence of renal biopsy findings other than diabetic glomerulopathy in type II diabetes mellitus. Nephrol Dial Transplant 7: 397-9.
176. Ritz E, Stefanski A, Lippen J (1995): Nephropathy in type II diabetes. J Nephrol 8: 128-32.
177. Rose G, Blackburn H, Gillum RF, Prineas RJ (1982): Cardiovascular Survey Methods. Geneva, World Health Organization, pp 162-5 (WHO monograph scries no. 56).
178. Rossing P, Hommel E, Smidt UM, Parving H-H (1993): Impact of arterial blood pressure and albuminuria on the progression of diabetic nephropathy in IDDM patients. Diabetes 42: 715-9.
179. Rowe JW, Andres R, Tobin JD, Norris AH, Shock NW (1976): The effect of age on creatinine clearance in men: across-sectional and longitudinal study. J Geromol 31: 155-63.
180. Ruggenenti P, Mosconi L, Bianchi L, Cortesi L, Campana M, Pagani G, Mecca G, Remuzzi G (1994): Long-term treatment with either enalapril or nitrendipine stabilizes albuminuria and increases glomerular filtration rate in non-insulin-dependent diabetic patients. Am J Kidney Dis 24: 753-61.
181. Rutherford PA, Thomas TH, Taylor R, Wilkinson R (1994): Nephropathy and changes in sodium-lithium countertransport kinetics in type 2 (non-insulindependent) diabetes mellitus. J Hum Hypertens 8: 29-35.
182. Sano T, Hotta N, Kawamura T, Matsumae H, Chaya S, Sasaki H, Nakayama M, Hara T, Matsuo S, Sakamoto N (1996): Effects of long-term enalapril treatment on persistent microalbuminuria in normotensive Type 2 diabetic patients: Results of a 4-year, prospective, randomized study. Diabetic Med 13: 120-4.
183. Sawicki PT (1994): Smoking and diabetic nephropathy. In: Mogensen CE (ed). The kidney and hypertension in diabetes mellitus, 2nd edn, pp 133-40. Kluwer Academic Press, Boston.
184. Schmitz A, Vaeth M (1988a): Microalbuminuria: A major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients. Diabetic Med 5: 126-34.
185. Schmitz A, Gundersen HJG, Østerby R (1988b): Glomerular morphology by light microscopy in non-insulin-dependent diabetes mellitus. Lack of glomerular hypertrophy. Diabetes 37: 38-43.
186. Schmitz A, Christensen T, Taagehoej Jensen F (1989): Glomerular filtration rate and kidney volume in normoalbuminuric non-insulin-dependent diabetics-lack of glomerular hyperfiltration and renal hypertrophy in uncomplicated NIDDM. Scand J Clin Lab Invest 49: 103-8.
187. Schmitz A, Nyengaard JR, Bendtsen TF (1990): Glomerular volume in Type 2 (non-insulin-dependent) diabetes estimated by a direct and unbiased stereologic method. Lab Invest 62: 108-13.
188. Schmitz A, Væth M, Mogensen CE (1994): Systolic blood pressure relates to the rate of progression of albuminuria in NIDDM. Diabetologia 37: 1251-8.
189. Schneider DJ, Nordt TK, Sobel BE (1993): Attenuated fibrinolysis and accelerated atherogenesis in type 2 diabetic patients. Diabetes 42: 1-7.
190. Shimomura H, Spiro RG (1987): Studies on macromolecular components of human glomerular basement membrane and alterations in diabetes. Decreased levels of heparan sulfate proteoglycan and laminin. Diabetes 36: 374-81.
191. Silvario SP, Friedman R, Jobim de Azevedo M, Canani LH, Gross JL (1996): Five-year prospective study of glomerular filtration rate and albumin excretion rate in normofiltering and hyperfiltering normoalbuminuric NIDDM patients. Diabetes Care 19: 171-4.
192. Skøtt P, Vaag A, Bruun NE, Hother-Nielsen O, Gall M-A, Beck-Nielsen H, Parving H-H (1991): Effect of insulin on renal sodium handling in hyperinsulinaemic Type 2 (non-insulin-dependent) diabetic patients with peripheral insulin resistance. Diabetologia 34: 275-81.
193. Smith JB, Wade MB, Fineberg NS, Weinberger MH (1988): Influence of race, sex. and blood pressure on erythrocyte sodium transport in humans. Hypertension 12: 251-8.
194. Standl E, Stiegler H (1993): Microalbuminuria in a random cohort of recently diagnosed Type 2 (non-insulin-dependent) diabetic patients living in the Greater Munich Area. Diabetologia 36: 1017-20.
195. Steffes MW, Brown DM, Mauer SM (1978): Diabetic glomerulopathy following unilateral nephrectomy in the rat. Diabetes 27: 35-41.
196. Steffes MW, Østerby R, Chavers B, Mauer SM (1989): Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 38: 1077-81.
197. Stehouwer CDA, Nauta JJP, Zeldenrust GC, Hackeng WHL, Donker AJM, Ottolander GJH (1992): Urinary albumin excretion, cardiovascular disease and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 340: 319-23.
198. Stephens GW, Gillaspy JA, Clyne D, Mejia A, Pollak VE (1990): Racial differences in the incidence of end-stage renal disease in types I and II diabetes mellitus. Am J Kidney Dis 15: 562-7.
199. Stiegler H, Standl E, Schultz K, Roth R, Lehmacher W (1992): Morbidity, mortality, and albuminuria in Type 2 diabetic patients: a three-year prospective study of a random cohort in general practice. Diabetic Med 9: 646-53.
200. Striker GE, Agodoa LL, Held P, Doi T, Conti F, Striker LJ (1991): Kidney disease of diabetes mellitus (diabetic nephropathy): Perspectives in the United States. J Diabetic Compl 5: 51-2.
201. Taft JL, Billson VR, Nankervis A, Kincaid-Smith P, Martin FIR (1990): A clinical-histological study of individuals with diabetes mellitus and proteinuria. Diabetic Med 7: 215-21.
202. Taft JL, Nolan CJ, Yeung SP, Hewitson TD, Martin FIR (1994): Clinical and histological correlations of decline in renal function in diabetic patients with proteinuria. Diabetes 43: 1046-51.
203. Tamsma JT, van den Born J, Bruijn JA, Assmann KJM, Weening JJ, Berden JHM, Wieslander J, Schrama E, Hermans J, Veerkamp JH, Lemkes HHPJ, van der Woude FJ (1994): Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane. Diabetologia 37: 313-20.
204. Tomlanovich S, Deen WM, Jones HW III, Schwanz HC, Myers B (1987): Functional nature of the glomerular injury in progressive diabetic glomerulopathy. Diabetes 36: 556-65.
205. Torffvit O, Agardh E, Agardh C-D (1991): Albuminuria and associated medical risk factors: A cross-sectional study of 451 Type II (non-insulin-dependent) diabetic patients. Part 2. J Diabetic Comp 5: 29-34.
206. Trevisan M, Ostrow D, Cooper RS, Sempos C, Stamler J (1984): Sex and race differences in sodium-lithium countertransport and red cell sodium concentration. Am J Epidemiol 120: 537-41.
207. Trevisan M, Vaccaro O, Laurenzi M, De Chiara F, Di Muro M, Jacone R, Franzese A (1988): Hypertension, non-insulin-dependent diabetes and intracellular sodium metabolism. Hypertension 11: 264-8.
208. Tung P, Levin SR (1988): Nephropathy in non-insulin-dependent diabetes mellitus. Am J Med 85 (suppl. 5A): 131-6.
209. United Kingdom Prospective Diabetes Study Group (1991): United Kingdom Prospective Diabetes Study. VIII. Study design, progress and performance. Diabetologia 34: 877-90.
210. Uusitupa MIJ, Niskanen LK, Siitonen O, Voutilainen E, Pyörälä K (1993): Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in Type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 36: 1175-84.
211. Venkatachalam MA, Rennke HG (1978): The structural and molecular basis of glomerular filtration. Circ Res 43: 337-47.
212. Vernier RL, Steffes MW, Sisson-Ross S, Mauer SM (1992): Heparan sulfate proteoglycan in the glomerular basement membrane in type 1 diabetes mellitus. Kidney Int 41: 1070-80.
213. Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H (1982): Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet i: 1430-2.
214. Viberti GC, Mackintosh D, Keen H (1983): Determinants of the penetration of proteins through the glomerular barrier in insulin-dependent diabetes mellitus. Diabetes 32 (Suppl 2): 92-95.
215. Viberti GC, Mogensen CE, Passa P, Bilous R, Mangili R (1994): St Vincent Declaration. 1994: Guidelines for the prevention of diabetic renal failure. In: Mogensen CE (ed.), The kidney and hypertension in diabetes mellitus, 2nd ed. pp 515-27. Kluwer Academic Publishers, Boston.
216. Vora JP, Dolben J, Dean JD, Thomas D, Williams JD, Owens DR, Peters JR (1992): Renal hemodynamics in newly presenting non-insulin dependent diabetes mellitus. Kidney Int 41: 829-35.
217. Vora JP, Dolben J, Williams JD, Peters JR, Owens DR (1993): Impact of initial treatment on renal function in newly-diagnosed Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 36: 734-40.
218. Walker JD, Close CF, Jones SL, Rafftery M, Keen H, Viberti GC, Østerby R (1992): Glomerular structure in Type 1 (insulin-dependent) diabetic patients with normo- and microalbuminuria. Kidney Int 41: 741-8.
219. Wang PH, Lau J, Chalmers TC (1993): Meta-analysis of effects of intensive blood-glucose control on late complications of type I. Lancet 341: 1306-94.
220. Weibel ER (1980). Stereological methods: Practical methods for biological morphometry. Vol 1. Academic Press, New York.
221. WHO (1979): Arterial hypertension, Report of a WHO expert committee on hypertension. World Health Organisation. Technical Report Series No 625 Geneva.
222. WHO Study Group (1985): Report on diabetes mellitus. World Health Organisation, Technical Report Series No 727, Geneva.
223. Wiinberg N, Nygart J, Sengeløv H, Nielsen PE (1988): Oscillometric measurement of the blood pressure. Ugeskr Laeger 150: 1282-4.
224. Williams JD, Coles GA (1994): Proteinuria-A direct cause of renal morbidity? Kidney Int 45: 443-50.
225. Wingard DL, Barren-Connor EL, Scheidt-Nave C, McPhilips JB (1993): Prevalence of cardiovascular and renal complications in older adults with normal or impaired glucose tolerance or NIDDM. Diabetes Care 16: 1022-5.
226. Winocour PH, Harland JOE, Millar JP, Laker MF, Alberti KGMM (1992): Microalbuminuria and associated cardiovascular risk factors in the community. Atherosclerosis 93: 71-81.
227. Wirta O, Pasternack A, Mustonen J, Oksa H, Koivula T, Helin H (1995): Albumin excretion rate and its relation to kidney disease in non-insulin-dependent diabetes mellitus. J Internal Med 237: 367-73.
228. Wirta O, Pasternack A, Laippala P, Turjanmaa V (1996): Glomerular filtration rate and kidney size after six years disease duration in non-insulin-dependent diabetic subjects. Clin Nephrol 45: 10-7.
229. Yudkin J, Forrest RD, Jackson CA (1988): Microalbuminuria as a predictor of vascular disease in non-diabetic subjects. Lancet 11: 530-33.
230. Zau R, Meyer TW, Rennke HG, Brenner BM (1985): Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Nath Acad Sci: 82: 5963-7.
231. Zeller K, Whittaker E, Sullivan L, Roskin P, Jacobson HR (1991): Effect of restricting dietary protein on progression of renal failure in patients with insulin-dependent diabetes mellitus. N Engl J Med 324: 78-84.
232. Zimmet P, King H (1987): Classification and diagnosis of diabetes mellitus. In: Alberti KGMM, Krall LP (eds.), The Diabetes Annual/3, pp 1-14, Elsevier, Amsterdam.
233. Østerby R, Gundersen HJG, Nyberg G, Aurell M (1987): Advanced diabetic glomerulopathy. Quantitative structural characterization of non-occluded glomeruli Diabetes 36: 612-9.
234. Øslerby R, Parving H-H, Nyberg G, Hommel E, Jørgensen HE, Løkkegaard S, Svalander C (1988): A strong correlation between glomerular filtration rate and filtration surface in diabetic nephropathy. Diabetologia 31: 265-70.
235. Østerby R, Parving H-H, Hommel E, Jørgensen HE, Løkkegaard H (1990): Glomerular structure and function in diabetic nephropathy. Early to advanced stages. Diabetes 39: 1057-63.
236. Østerby R (1992): Glomerular structural changes in Type 1 (insulin-dependent) diabetes mellitus: causes, consequences, and prevention. Diabetologia 35: 803-12.
237. Østerby R (1993a): Renal pathology in diabetes mellitus. Current Opinion in Nephrology and Hypertension 2: 475-83.
238. Østerby R, Gall M-A, Schmitz A, Nielsen FS, Nyberg G, Parving H-H (1993b): Glomerular structure and function in proleinuric Type 2 (non-insulin-dependent) diabetic patients. Diabetologia 36: 1064-70.